CAPPELLI, GIULIA
 Distribuzione geografica
Continente #
AS - Asia 1.167
NA - Nord America 797
EU - Europa 426
SA - Sud America 175
AF - Africa 28
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.599
Nazione #
US - Stati Uniti d'America 759
SG - Singapore 449
CN - Cina 281
IT - Italia 232
BR - Brasile 143
HK - Hong Kong 138
VN - Vietnam 94
FR - Francia 55
KR - Corea 50
BD - Bangladesh 47
NL - Olanda 40
JP - Giappone 39
GB - Regno Unito 27
CA - Canada 17
FI - Finlandia 15
IN - India 15
DE - Germania 14
PH - Filippine 11
ZA - Sudafrica 9
AR - Argentina 8
CI - Costa d'Avorio 8
IQ - Iraq 8
MX - Messico 8
PL - Polonia 8
EC - Ecuador 7
ID - Indonesia 7
IE - Irlanda 7
IL - Israele 7
TR - Turchia 7
SE - Svezia 6
CO - Colombia 5
ES - Italia 5
CL - Cile 4
CR - Costa Rica 4
PY - Paraguay 4
RU - Federazione Russa 4
AU - Australia 3
CM - Camerun 3
KZ - Kazakistan 3
NO - Norvegia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
HR - Croazia 2
JO - Giordania 2
LB - Libano 2
LV - Lettonia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PE - Perù 2
VE - Venezuela 2
AT - Austria 1
BH - Bahrain 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UA - Ucraina 1
UG - Uganda 1
Totale 2.599
Città #
Santa Clara 260
Singapore 245
San Jose 171
Hong Kong 132
Hefei 119
Rome 117
Beijing 69
Seoul 50
Lauterbourg 46
Ashburn 40
Ho Chi Minh City 38
Tokyo 33
New York 23
Council Bluffs 20
Los Angeles 19
Hanoi 17
Montelibretti 13
Dallas 12
São Paulo 12
Buffalo 11
Lappeenranta 10
Milan 10
Abidjan 8
Southampton 8
Cesano Boscone 7
Denver 7
Warsaw 7
Chicago 6
Da Nang 6
Dublin 6
Haiphong 6
Loerrach 6
Sesto San Giovanni 6
Amsterdam 5
Atlanta 5
Curitiba 5
Houston 5
Johannesburg 5
London 5
Minamishinagawa 5
Montreal 5
Naples 5
Verona 5
Bengaluru 4
Brasília 4
Governador Valadares 4
Guayaquil 4
Manchester 4
Marion 4
Mumbai 4
Queens 4
Salvador 4
Shanghai 4
Agawam 3
Ankara 3
Astana 3
Baghdad 3
Belo Horizonte 3
Boydton 3
Brescia 3
Buenos Aires 3
Frankfurt am Main 3
Guangzhou 3
Helsinki 3
Maringá 3
Medellín 3
Newark 3
Nuremberg 3
Orem 3
Phoenix 3
Quito 3
Rio de Janeiro 3
St Louis 3
Stockholm 3
Toronto 3
Yaoundé 3
Acalanes Ridge 2
Amman 2
Anderson 2
Annapolis 2
Asunción 2
Athens 2
Aversa 2
Bagnaria Arsa 2
Baltimore 2
Beirut 2
Betim 2
Bologna 2
Brooklyn 2
Carosino 2
Charlotte 2
Chengdu 2
Chino Hills 2
Clarksville 2
Columbus 2
Cunupia 2
Detroit 2
Dhaka 2
Elk Grove Village 2
Fair Lawn 2
Totale 1.747
Nome #
Brevetto italiano su un fitoterapico attivo verso il melanoma metastatico umano 92
Cinnamomum zeylanicum blume essential oil inhibits metastatic melanoma cell proliferation by triggering an incomplete tumour cell stress response 91
V delta 2 T-lymphocyte responses in cord blood samples from Italy and Cote d'Ivoire 84
Seasonal pattern of hospitalization from acute respiratory infections in Yaoundé, Cameroon 78
Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in Cameroon 76
Human immunodeficiency virus type 1 intersubtype recombinants predominate in the AIDS epidemic in Cameroon 70
A new CpG ODN induces a fine- tuning of Innate response resulting in Mycobacterium tuberculosis containment 68
Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies 62
A Corylus avellana L. extract enhances human macrophage bactericidal response against Staphylococcus aureus by increasing the expression of antiinflammatory and iron metabolism genes 59
Performance characteristics of INDICAID antigen rapid diagnostic test on SARS-CoV-2 samples during the omicron wave in Cameroon 58
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out stavudine 57
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon 56
Lavandula angustifolia mill. Essential oil exerts antibacterial and anti-inflammatory effect in macrophage mediated immune response to staphylococcus aureus 55
High concordance in SARSCoV-2 detection between automated ( Abbott m2000) and manual ( DaAn gene) RT-PCR systems: The EDCTP PERFECT-Study in Cameroon 54
Molecular Epidemiology of HIV Type 1 CRF02_AG in Cameroon and African Patients Living in Italy 53
A manifesto for the valorization of wild edible plants 53
A new Mycobacterium tuberculosis smooth colony reduces growth inside human macrophages and represses PDIM Operon gene expression. Does an heterogeneous population exist in intracellular mycobacteria? 50
A new Mycobacterium tuberculosis smooth colony reduces growth inside human macrophages and represses PDIM Operon gene expression. Does an heterogeneous population exist in intracellular mycobacteria? 48
A systematic review on the antimicrobial properties of mediterranean wild edible plants: we still know too little about them, but what we do know makes persistent investigation worthwhile 47
Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon 47
Integrated Seroprevalence and Genome‐Based Study of SARS‐CoV‐2 Viral Strains in N′Djamena: Insights Into Chad's COVID‐19 Epicenter 45
Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries 45
SARS-CoV-2 seroprevalence and associated factors among outpatient attendees at health facilities in different provinces in Chad 44
Laboratory based surveillance of HIV-1 acquired drug resistance in Cameroon: implications for use of Tenofovir-Lamivudine-Dolutegravir (TLD) as second- or third-line regimens 44
Profiling of Mycobacterium tuberculosis gene expression during human macrophage infection: upregulation of the alternative sigma factor G, a group of transcriptional regulators, and proteins with unknown function. 42
SELECTIVE EXPANSION OF CYTOTOXIC T-LYMPHOCYTES WITH A CD4(+)CD56(+) SURFACE PHENOTYPE AND A T-HELPER TYPE-1 PROFILE OF CYTOKINE SECRETION IN THE LIVER OF PATIENTS CHRONICALLY INFECTED WITH HEPATITIS-B VIRUS 42
Presence of neutralizing SARS-CoV-2 antibodies inasymptomatic population of N'Djamena, Chad 40
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 40
Computational and experimental validation of phthalocyanine and hypericin as effective SARS-CoV-2 fusion inhibitors 39
Macrophages sensitivity to static magnetic fields 39
The COVID-19 wave was already here: High seroprevalence of SARS-CoV-2 antibodies among staff and students in a Cameroon University 38
Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis. 38
XBB.1, BQ1.1 and atypical BA.4.6/XBB.1 recombinants predominate current SARS-CoV-2 wavelets with flu-like symptoms in Cameroon: a snapshot from genomic surveillance 38
Differentiation of monocytes into CD1a- dendritic cells correlates with disease progression in HIV-infected patients 37
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon 37
Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon 36
Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso. 34
Measure of viral load by using the Abbott Real-Time HIV-1 assay on dried blood and plasma spot specimens collected in 2 rural dispensaries in Cameroon 33
Computer-based design of an HLA-haplotype and HIV-clade independent cytotoxic T-lymphocyte (CTL) assay for monitoring HIV-specific immunity 33
Implementation of HIV Early Infant Diagnosis and HIV Type 1 RNA Viral Load Determination on Dried Blood Spots in Cameroon: Challenges and Propositions. 33
RESPONSE TO TETANUS TOXOID PRIMARY IMMUNIZATION IN CHILDREN BORN TO HIV-SEROPOSITIVE MOTHERS 33
Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon. 31
Lower anti-HIV-1 neutralization in HIV-infected children with CD4(+) T cell depletion: opposite correlation to that in adults 31
Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon. 31
Medicinal flora of Chad: an ethnobotanical investigation into traditional healing practices in N’Djamena city 31
Human macrophage gamma interferon decreases gene expression but not replication of a Mycobacterium tuberculosis: Analysis of the host-pathogen reciprocal influence on transcription in a comparison of strains H37Rv and CMT97 31
Mycobacterium tuberculosis enhances iNOS mRNA expression and HIV replication in human astrocytoma cells 30
Human Leucocyte Antigen Class I Diversity among Human Immunodeficiency Virus Exposed Negative and Positive Children in Cameroon 29
Cord Blood V gamma 2V delta 2 T Cells Provide a Molecular Marker for the Influence of Pregnancy-Associated Malaria on Neonatal Immunity 29
The effects of medicinal wild edible plants in human innate immunity vs intracellular bacterial pathogen 27
Implementation of HIV Early Infant Diagnosis and HIV Type 1 RNA Viral Load Determination on Dried Blood Spots in Cameroon: Challenges and Propositions 26
Tuberculosis and lung cancer. An interesting case study. 26
Human cord blood gamma delta T cells expressing public V gamma 2 chains dominate the response to bisphosphonate plus interleukin-15 25
HIV-1 Drug Susceptibility to Potential Second- and Third-Line Antiretroviral Regimens among Cameroonian Patients: Evidence from a Cross-sectional Design 25
HIV-1 Drug Resistance in Children and Implications for Pediatric Treatment Strategies: A Systematic Review and Meta-Analysis 23
Performance of anti-SARS-CoV-2 IgG/IgM rapid diagnostic test in N’Djamena, Chad: evidence from a clinical perspective during an outbreak response 22
Allele frequency of Hemoglobin S among patients with uncomplicated Plasmodium falciparum malaria in N'Djamena, Chad 21
Socio-cultural, educational, and behavioral determinants of severe acute malnutrition among children aged 6 to 59 months: a study at the Ati Nord Health Center, Chad 21
Human immunodeficiency virus type 1 infection modulates the interleukin (IL)-1 beta and IL-6 responses of human macrophages to CD40 ligand stimulation 20
Four years after its creation: what role for the Laboratoire des Grandes Épidémies Tropicales (LAGET) in epidemic response in Chad? 19
Tackling Human Resources in Africa How one institute leverages overseas talent to develop its research strategy. 19
Central Africa and the COVID-19 paradox: lessons from a silent spread 18
125 years of immunology: from the 2025 Nobel Prize to research prospects in Chad 18
Sub-Saharan medicinal plants and their medical use: a semi-systematic review 18
Microbial safety of community water sources in Mbouo-Bandjoun, Cameroon: a preliminary assessment 18
Updates on the Clinical Epidemiology of HIV-1 Group O Strains in Cameroon and Potential Implications on Diagnosis and Treatment Strategies 17
null 9
Totale 2.683
Categoria #
all - tutte 8.718
article - articoli 8.238
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202427 0 0 0 0 0 0 0 0 1 0 15 11
2024/2025904 1 4 56 34 252 33 31 57 17 36 201 182
2025/20261.710 97 125 111 219 205 57 219 253 91 120 77 136
2026/202742 42 0 0 0 0 0 0 0 0 0 0 0
Totale 2.683